“…Cefquinome is one of the fourth‐generation cephalosporins developed exclusively for use in animals and has been used in the treatment of respiratory tract diseases, acute mastitis, and foot rot in cattle, calf septicemia, respiratory diseases in pigs, metritis,mastitis, and agalactia syndrome in sows, foal septicemia, and respiratory tract diseases in horses (CVMP, , , ). Pharmacokinetics of cefquinome following intramuscular (IM) administration have been reported in lactating cows (Ehinger, Schmidt, & Kietzmann, ), goats (Dumka, Dinakaran, Bibhuti, & Satyavan, ), sheep (Tohamy, ; Uney, Altan, & Elmas, ), and camels (Al‐Taher, ), and the pharmacokinetics following intravenous (IV) administration have been reported in buffalo calves (Dinakaran, Dumka, Ranjan, Balaje, & Sidhu, ), horses (Dumka et al., ) and goats (Dumka et al., ). However, there are no published report on the disposition and bioavailability of cefquinome following IM administration in buffalo calves.…”